Global Chronic Myeloid Leukemia Epidemiology and Patient Flow Report 2017 - Prevalence, Diagnosis Rate & Treatment Rate 2016-2025 - Research and Markets

DUBLIN, Jan 24, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Chronic Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2017" report to their offering.

The results of the Chronic Myeloid Leukemia patients study are announced in this new report Global Chronic Myeloid Leukemia Epidemiology and Patient Flow Analysis Report 2017'.

The report provides insights into Chronic Myeloid Leukemia epidemiology, Chronic Myeloid Leukemia diagnosed patients, and Chronic Myeloid Leukemia treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Chronic Myeloid Leukemia derived from epidemiological analysis, percentage of patients diagnosed with Overactive Bladder, and percentage of patients treated with a therapy.

The study helps executives estimate Chronic Myeloid Leukemia market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Chronic Myeloid Leukemia prevalence, Chronic Myeloid Leukemia diagnosis rate, and Chronic Myeloid Leukemia treatment rate for the period 2016 - 2025.

Key Features of the Report:

• Chronic Myeloid Leukemia Patient Flow
• Chronic Myeloid Leukemia Prevalence
• Chronic Myeloid Leukemia Diagnosed Patients
• Chronic Myeloid Leukemia Treated Patients

Key Topics Covered:

1. Chronic Myeloid Leukemia Disease Definition

2. Global Chronic Myeloid Leukemia Patient Flow

3. Chronic Myeloid Leukemia Patient Flow in the US

4. Chronic Myeloid Leukemia Patient Flow in Europe

5. Chronic Myeloid Leukemia Patient Flow in Germany

6. Chronic Myeloid Leukemia Patient Flow in France

7. Chronic Myeloid Leukemia Patient Flow in Spain

8. Chronic Myeloid Leukemia Patient Flow in Italy

9. Chronic Myeloid Leukemia Patient Flow in UK

10. Chronic Myeloid Leukemia Patient Flow in Japan

For more information about this report visit http://www.researchandmarkets.com/research/xvb6wl/global_chronic

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[e-mail]

For E.S.T Office Hours Call [phone]
For U.S./CAN Toll Free Call [phone]
For GMT Office Hours Call [phone]

U.S. Fax: [phone]
Fax (outside U.S.): [phone]